Complement Component 1, s Subcomponent Overexpression is an Independent Poor Prognostic Indicator in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder

scientific article published on 30 June 2016

Complement Component 1, s Subcomponent Overexpression is an Independent Poor Prognostic Indicator in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.7150/JCA.15339
P932PMC publication ID4964123
P698PubMed publication ID27471555

P50authorWen Jeng WuQ72138148
P2093author name stringChien-Feng Li
Peir-In Liang
Hong-Lin He
I-Wei Chang
Wei-Ming Li
Ti-Chun Chan
Victor Chia-Hsiang Lin
Bi-Wen Yeh
Alex Chien-Hwa Liao
P2860cites workCancer statistics, 2014Q27861018
Natural innate and adaptive immunity to cancerQ29620313
Morphologic evidence that analgesic-induced kidney pathology contributes to the progression of tumors of the renal pelvisQ33753954
Comparative gene expression profiling analysis of urothelial carcinoma of the renal pelvis and bladderQ33772260
Glutathione Peroxidase 7 Suppresses Bile Salt-Induced Expression of Pro-Inflammatory Cytokines in Barrett's CarcinogenesisQ33794355
Complement System Part I - Molecular Mechanisms of Activation and RegulationQ34481071
Aristolochic acid nephropathy: a worldwide problemQ34590610
Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancerQ34615593
Dipeptidyl-peptidase IV activity is correlated with colorectal cancer prognosis.Q35195876
Complement receptor 1 genetic variants contribute to the susceptibility to gastric cancer in chinese populationQ35631618
CDCA5 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladderQ35682594
Adjuvant Chemotherapy Correlates with Improved Survival after Radical Cystectomy in Patients with pT3b (Macroscopic Perivesical Tissue Invasion) Bladder CancerQ35856850
Clinical significance of kallikrein-related peptidase-4 in oral cancerQ36079284
Necdin Overexpression Predicts Poor Prognosis in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary BladderQ36563911
SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial CarcinomaQ36567906
Molecular mechanisms underlying chronic inflammation-associated cancersQ37605343
Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973–2005Q37786352
Factors affecting the occurrence of urothelial tumors in dye workers exposed to aromatic aminesQ38564530
Chronic inflammation in urothelial bladder cancerQ38564597
Influence of the C5a-C5a receptor system on breast cancer progression and patient prognosisQ38736616
Potential biomarkers for paclitaxel sensitivity in hypopharynx cancer cellQ39051376
Conformationally altered hyaluronan restricts complement classical pathway activation by binding to C1q, C1r, C1s, C2, C5 and C9, and suppresses WOX1 expression in prostate DU145 cells.Q40201212
BCAT1 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladderQ40738932
HAS3 underexpression as an indicator of poor prognosis in patients with urothelial carcinoma of the upper urinary tract and urinary bladderQ40986079
GPX2 underexpression indicates poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladderQ41153833
Site-directed mutagenesis of hamster complement C1S: characterization with an active form-specific antibody and possible involvement of C1S in tumorigenicityQ41192366
FGF7 Over Expression is an Independent Prognosticator in Patients with Urothelial Carcinoma of the Upper Urinary Tract and BladderQ41522928
Urothelial cancer at different tumour sites: role of smoking and habitual intake of analgesics and laxatives. Results of the Berlin Urothelial Cancer StudyQ41703609
Tumorigenicity of BALB3T3 A31 cells transfected with hamster-complement-C1s cDNA.Q42795749
Cigarette smoking and cancers of the renal pelvis and ureterQ43624660
Unusually high incidence of upper urinary tract urothelial carcinoma in TaiwanQ43981522
Factors influencing post-recurrence survival in bladder cancer following radical cystectomy.Q46642513
Clinical and epidemiological features of patients with genitourinary tract tumour in a blackfoot disease endemic area of TaiwanQ47740871
Behavior of Urothelial Carcinoma With Respect to Anatomical LocationQ57565205
Multivariate analysis of survival, recurrence, progression and development of mestastasis in T1 and T2a transitional cell bladder carcinomaQ77839108
P433issue11
P921main subjectoverexpressionQ61643320
P304page(s)1396-1405
P577publication date2016-06-30
P1433published inJournal of CancerQ6294901
P1476titleComplement Component 1, s Subcomponent Overexpression is an Independent Poor Prognostic Indicator in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder
P478volume7

Reverse relations

cites work (P2860)
Q91013849Context-dependent roles of complement in cancer
Q37514045Downregulation of RNF128 Predicts Progression and Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Tract and Urinary Bladder
Q48247536Evaluation of anti-sepsis activity by compounds with high affinity to lipid a from HuanglianJiedu decoction
Q33776709High Expression of Aldolase B Confers a Poor Prognosis for Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy
Q33702374High Expression of EphA4 Predicted Lesser Degree of Tumor Regression after Neoadjuvant Chemoradiotherapy in Rectal Cancer
Q41721791High Immunoreactivity of DUOX2 Is Associated With Poor Response to Preoperative Chemoradiation Therapy and Worse Prognosis in Rectal Cancers
Q92783454Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent Chemoradiotherapy
Q50243745The complement system: a double edge sword in tumor progression
Q38698128The prognostic significance of preoperatively assessed AST/ALT (De Ritis) ratio on survival in patients underwent radical cystectomy